ArticlemSphere2019
Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe.
Open access · goldAbstract read
In one paragraph
Article in mSphere, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 33 citations in OpenAlex.
- Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.Nature communications · 2021Trial
- Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanil.EMBO molecular medicine · 2025Article
- Correlative humoral and cellular immunity to genetically attenuated malaria parasites in humans.iScience · 2025Article
- Antibody responses in Burkinabe children againstFrontiers in immunology · 2025Article
- PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults.EBioMedicine · 2024Article
- Temporal and spatial analysis of Plasmodium falciparum genomics reveals patterns of parasite connectivity in a low-transmission district in Southern Province, Zambia.Malaria journal · 2023Article
- Declining Age-Specific Seroprevalence and Seroconversion Rates in Plasmodium falciparum from 2009 to 2018 Documents Progress toward Malaria Elimination in Southern Zambia.The American journal of tropical medicine and hygiene · 2023Article
- A Bayesian hierarchical model for signal extraction from protein microarrays.Statistics in medicine · 2023Article
- Novel bioinformatic methods and machine learning approaches reveal candidate biomarkers of the intensity and timing of past exposure to Plasmodium falciparum.PLOS global public health · 2023Article
- Scientific Findings of the Southern and Central Africa International Center of Excellence for Malaria Research: Ten Years of Malaria Control Impact Assessments in Hypo-, Meso-, and Holoendemic Transmission Zones in Zambia and Zimbabwe.The American journal of tropical medicine and hygiene · 2022Article
- Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial.Malaria journal · 2022Article
- Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens.NPJ vaccines · 2022Article
- A pre-processing pipeline to quantify, visualize, and reduce technical variation in protein microarray studies.Proteomics · 2022Article
- Article
- Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots.Malaria journal · 2021Article
- PvMSP8 as a NovelPathogens (Basel, Switzerland) · 2021Article
- Naturally Acquired Humoral Immunity AgainstFrontiers in immunology · 2020Review
- Looking for Needles in the Plasmodial Haystack.mSphere · 2019Article
Corrections and comments
- Commented on by
Authors and funding
18 authors at 5 institutions in 3 countries.
Tamaki KobayashiJohns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Aarti JainVaccine Research & Development Center, Department of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA.
Li LiangVaccine Research & Development Center, Department of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA.
Joshua M ObieroVaccine Research & Development Center, Department of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA.ORCID 0000-0001-9741-512X
Harry HamapumbuMacha Research Trust, Choma, Zambia.
Jennifer C StevensonJohns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Philip E ThumaJohns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
James LupiyaTropical Diseases Research Centre, Ndola, Zambia.
Mike ChapondaTropical Diseases Research Centre, Ndola, Zambia.
Modest MulengaTropical Diseases Research Centre, Ndola, Zambia.
Edmore MaminiBiomedical Research and Training Institute, Harare, Zimbabwe.
Sungano MharakurwaBiomedical Research and Training Institute, Harare, Zimbabwe.
Lovemore GwanzuraBiomedical Research and Training Institute, Harare, Zimbabwe.
Shungu MunyatiBiomedical Research and Training Institute, Harare, Zimbabwe.
Susan MutambuNational Institute of Health Research, Harare, Zimbabwe.
Philip FelgnerVaccine Research & Development Center, Department of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA.
D Huw DaviesVaccine Research & Development Center, Department of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA ddavies@uci.edu.
William J MossJohns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
University of California, Irvine · USBiomedical Research and Training Institute · ZWJohns Hopkins University · USTropical Diseases Research Centre · ZMGolden Valley Agricultural Research Trust · ZM
Funding
TransmissionU19AI089680 · NIAID · JOHNS HOPKINS UNIVERSITY · PI WILLIAM J MOSS · 2010 to 2026
$25.6MTransmissionU19AI089686 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ZIMMERMAN, PETER A. · 2010 to 2016
$9.9MPredicting naturally acquired humoral immunity against malariaR01AI095916 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI FELGNER, PHILIP LOUIS · 2012 to 2016
$2.1MNIAID NIH HHS R01 AI095916NIAID NIH HHS U19 AI089680NIAID NIH HHS U19 AI089686
Abstract
Antibodies to
Indexed as
Antibody FormationAdolescentAdultAgedAge FactorsAntibodies, ProtozoanAntigens, ProtozoanBiomarkersChildChild, PreschoolCommunity ParticipationCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansMalariaAntibodies, ProtozoanAntigens, ProtozoanBiomarkersmalariaPlasmodium falciparumproteomicsserologysurveillance studies
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.